2022 Annual Meeting | S9 - Neuromodulation and Alternatives to Reduce Opioid Use in Pain Management
Program Materials Program Evaluations
| 01:00 PM - 01:12 PM PDT | Speaker |
2022 Mitchell B. Max Award for Neuropathic Pain: This award recognizes an individual for outstanding work in the field of neuropathic pain for either a single contribution or for lifetime achievement.
John Markman, MD, FAAN |
| 01:00 PM - 01:00 PM PDT | Speaker |
walk in slides
John Markman, MD, FAAN |
| 01:12 PM - 01:24 PM PDT | Abstract |
002 - Pramipexole Improves the Analgesic Properties of Low-dose Morphine in the Treatment of Acute Pain
Ryan Patton |
| 01:24 PM - 01:36 PM PDT | Abstract |
003 - Repetitive Transcranial Magnetic Stimulation for the Treatment of Fibromyalgia: An open label clinical trial
Nilson Nogueira Mendes Neto, MD |
| 01:36 PM - 01:48 PM PDT | Abstract |
004 - Non-Invasive Brain Stimulation For Diabetic Neuropathic Pain
Ciro Ramos Estebanez, MD, PhD, MBA, FAAN |
| Felipe Fregni | No disclosure on file |
| Ciro Ramos Estebanez, MD, PhD, MBA, FAAN | The institution of Dr. Ramos Estebanez has received research support from NIH. Dr. Ramos Estebanez has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Krishnakant Shah Aka Khandelwal | Mr. Shah Aka Khandelwal has nothing to disclose. |
| Persen Sukpornchairak, MD | Dr. Sukpornchairak has nothing to disclose. |
| Ryan Patton | Mr. Patton has nothing to disclose. |
| Allison Mainhart | No disclosure on file |
| John Markman, MD, FAAN | Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio Biosciences. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem Therapeutics. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Trevena. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grunenthal. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grunenthal. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lateral Pharma. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avenue Therapeutics. Dr. Markman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Markman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix Pharmaceuticals. Dr. Markman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Flowonix. Dr. Markman has stock in Yellowblack Corporation. |
| J. D. Bartleson, MD, FAAN | Dr. Bartleson has nothing to disclose. |
| Ligia V. Onofrei, MD | Dr. Onofrei has nothing to disclose. |
| Nilson Nogueira Mendes Neto, MD | Dr. Nogueira Mendes Neto has nothing to disclose. |